跳至主要内容
临床试验/EUCTR2010-018447-34-GB
EUCTR2010-018447-34-GB进行中(未招募)1 期

Investigation of dendritic cell vaccine immunotherapy in paediatric high grade glioma - DC vaccine trial

Great Ormond Street Hospital for Children NHS Trust0 个研究点目标入组 20 人开始时间: 2011年8月17日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Histologically confirmed high-grade glioma (including anaplastic astrocytoma, glioblastoma, anaplastic oligodendroglioma, anaplastic oligoastrocytoma and anaplastic variants of ganglioglioma and pleomorphic xanthoastrocytoma)
  • Substantial debulking surgery (primary treatment or relapse group) or small volume recurrence (relapse group).
  • Available tumour lysate for DC pulsing
  • Informed consent
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range 0
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range 0

排除标准

  • Brain stem glioma
  • Metastatic spinal disease
  • Uncorrected hydrocephalus
  • Other ongoing chemotherapy
  • Positive serology for HIV, Hepatitis B or C, or positive TPHA test (syphilis)
  • Auto-immune disease (presence of autoantibodies in standard screen plus clinical features consistent with presence of antibodies)
  • Lansky/Karnovsky score less than 40 unless lower due to surgery
  • Pregnancy
  • Grade 4 CTC toxicity in any of the following categories
  • o Infection
  • o Dermatology/skin
  • o Gastrointestinal (excluding anorexia)
  • o Neurological (excluding sensory and audiological)

研究者

发起方
Great Ormond Street Hospital for Children NHS Trust

相似试验